Manuscripts
Showing 1583 manuscripts.
Characterising HIV drug resistance in cases of vertical transmission in the VESTED randomized antiretroviral treatment trial
Citation
Kevin Knowles, Lauren Ziemba, Sean Bremmel, Anne Coletti, Patrick Jean Philippe, Nahida Chakhtoura, Tichaona Vhembo, Haseena Cassim, Maxensia Owor, Lee Fairlie, Sikhulile Moyo, Violet Korutaro, Lameck Chinula, Marley D. Bishop, Shahin Lockman, Ceejay L. Boyce, Lisa M. Frenkel, Ingrid A. Beck, IMPAACT 2010 Team, Sheila M. Styrchak. Characterising HIV drug resistance in cases of vertical transmission in the VESTED randomized antiretroviral treatment trial. Journal of International AIDS Society. 2024. 96: 385-392. PMID: 39175843Year
2024
Journal
Journal of International AIDS Society
Study
IMPAACT 2010
Dolutegravir- Versus Efavirenz-Based Treatment in Pregnancy: Impact on Red Blood Cell Folate Concentrations in Pregnant Women and Their Infants
Citation
Benjamin Johnston, Terence Mohammed, Tichaona Vhembo, Enid Kabugho, Gerald Agaba Muzorah, Haseena Cassim, Lee Fairlie, Elizabeth S. Machado, Denise L. Jacobson, James S. Ngocho, Krista S. Crider, Roger L. Shapiro, Patricia DeMarrais, Lena Serghides, Sean Brummel, Nahida Chakhtoura, Mindy Zhang, Lameck Chinula, Christine M. Pfeiffer, Shahin Lockman, Cynthia A. Moore, Katie McCarthy. Dolutegravir- Versus Efavirenz-Based Treatment in Pregnancy: Impact on Red Blood Cell Folate Concentrations in Pregnant Women and Their Infants. Journal of Infectious Diseases. 2024. 230: 1224-1234. PMID: 38877762Year
2024
Journal
Journal of Infectious Diseases
Study
IMPAACT 2010
Markers of maternal bone and renal toxicity through 50 weeks postpartum: IMPAACT 2010 (VESTED) Trial
Citation
Laarni Igawa, Paul E. Sax, Anne Coletti, Lynda Stranix-Chibanda, Dorinda Mukura, IMPAACT 2010/VESTED study team and investigators, Lindie Rossouw, Gerhard Theron, Chelsea Krotje, Patrick Jean-Philippe, Nahida Chakhtoura, Haseena Cassim, Sisinyana Ruth Mathiba, Joel Maena, Gaerolwe Masheto, William Murtaugh, Sean S Brummel, Lee Fairlie, Lauren Ziemba, Judith Currier, John Shepherd, Risa Hoffman, Tapiwa Mbengeranwa, Lameck Chinula. Markers of maternal bone and renal toxicity through 50 weeks postpartum: IMPAACT 2010 (VESTED) Trial. Journal of Acquired Immune Deficiency Syndromes. 2024. 97: 172-179. PMID: 39250651Year
2024
Journal
Journal of Acquired Immune Deficiency Syndromes
Study
IMPAACT 2010
Lamivudine Dosing for Preterm Infants Exposed to HIV: a Population Pharmacokinetic Modelling and Simulation Study
Citation
Adrie Bekker, Edmund V. Capparelli, Mark Mirochnick, Diana F. Clarke, Mark F Cotton, Roger Shapiro, Katie McCarthy, Jack Moye, Avy Violari, Kulkanya Chokephaibulkit, Elaine Abrams, Martina Penazzato, Ted Ruel, Tim R. Cressey. Lamivudine Dosing for Preterm Infants Exposed to HIV: a Population Pharmacokinetic Modelling and Simulation Study. Journal of Antimicrobial Chemotherapy. 2024. 79: 2570-2574. PMID: 39092932Year
2024
Journal
Journal of Antimicrobial Chemotherapy
Study
P1106
Effects of combination antiretroviral therapy and nutritional rehabilitation on growth in children aged 6-36 months with severe acute malnutrition in IMPAACT protocol P1092
Citation
Christina Reding, Frederic Bone, Sarah Bradford, Diane Costello, Renee Browning, John Moye, Tichaona Vhembo, Sharon Mambiya, Esnath Msowoya, Maxensia Owor, Philippa Musoke, Blandina Theophil Mmbaga, James Samwel Ngocho, Camlin Tierney, Lauren Ziemba. Effects of combination antiretroviral therapy and nutritional rehabilitation on growth in children aged 6-36 months with severe acute malnutrition in IMPAACT protocol P1092. Journal of Paediatric Infectious Diseases. 2024. PMID: 38808862Year
2024
Journal
Journal of Paediatric Infectious Diseases
Study
P1092
Acceptability and tolerability of long-acting injectable cabotegravir or rilpivirine in the first cohort of virologically suppressed adolescents living with HIV (IMPAACT 2017/MOCHA): a secondary analysis of a phase 1/2, multicentre, open-label, non-comparative dose-finding study
Citation
Kristin Baltrusaitis, Jenny Huang, Barbara Heckman, Sarah Buisson, Dwight E. Yin, Ryan Milligan, Allison Agwu, Shawn Ward, Rohan Hazra, Carolyn Bolton-Moore, Conn Harrington, Aditya H. Gaur, Rodica M. Van Solingen-Ristea, IMPAACT 2017 Team, Cynthia C. McCoig, Adeola Adeyeye, Jared Kneebone, Vasiliki Chounta, Christiana Smith-Anderson, Elizabeth D. Lowenthal, Andres Camacho-Gonzalez, Jennifer Chapman, Ellen Chadwick, Rachel Ohrenschall, Allison Bearden, Katherine Calabrese, Herta Crauwels. Acceptability and tolerability of long-acting injectable cabotegravir or rilpivirine in the first cohort of virologically suppressed adolescents living with HIV (IMPAACT 2017/MOCHA): a secondary analysis of a phase 1/2, multicentre, open-label, non-comparative dose-finding study. Lancet HIV. 2024. 11: e222-e232. PMID: 38538161Year
2024
Journal
Lancet HIV
Study
IMPAACT 2017
Subsequent pregnancies in the IMPAACT 2010/VESTED Trial: high rate of adverse outcomes in women living with HIV
Citation
Roger Shapiro, Jeff Stringer, Grace Malonga, Renee Browning, Nahida Chakhtoura, Blandina Theophil Mmbaga, Tsungai P Mhembere, Ayotunde Omoz-Oarhe, Beatrice Nagaddya, Megeshinee Naidoo, Risa M Hoffman, Lee Fairlie, Shahin Lockman, Sean Brummel, IMPAACT 2010/VESTED Study Team, Lauren Ziemba, Anne Coletti, Lameck Chinula. Subsequent pregnancies in the IMPAACT 2010/VESTED Trial: high rate of adverse outcomes in women living with HIV. Journal of the International AIDS Society. 2024. 97: 150-155. PMID: 39742354Year
2024
Journal
Journal of the International AIDS Society
Study
IMPAACT 2010
Safety and pharmacokinetics of lopinavir/ritonavir oral solution in preterm and term infants starting before 3 months of age
Citation
Adrie Bekker, Jincheng Yang, Jiajia Wang, Mark F. Cotton, Mae Cababasay, Lubbe Wiesner, Jack Moye, Renee Browning, Firdose L. Nakwa, Helena Rabie, Avy Violari, Mark Mirochnick, Tim. R Cressey, Edmund V. Capparelli. Safety and pharmacokinetics of lopinavir/ritonavir oral solution in preterm and term infants starting before 3 months of age. Pediatric Infectious Disease Journal. 2024. 43: 355-360. PMID: 38190642Year
2024
Journal
Pediatric Infectious Disease Journal
Study
P1106
Safety and pharmacokinetics of oral and long-acting
injectable cabotegravir or long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre,
open-label, non-comparative, dose-finding st
Citation
Aditya H. Gaur, Edmund V. Capparelli, Katherine Calabrese, Kristin Baltrusaitis, Mark A Marzinke, Cynthia McCoig, Rodica M. Van Solingen-Ristea, Sisinyana Ruth Mathiba, Adeola Adeyeye, John H. Moye, Barbara Heckman, Elizabeth D. Lowenthal, Shawn Ward, Ryan Milligan, Pearl Samson, Brookie M. Best, Conn M. Harrington, Susan L. Ford, Jenny Huang, Herta Crauwels, Kati Vandermeulen, Allison L. Agwu, Christiana Smith-Anderson, Andres Camacho-Gonzalez, Pradthana Ounchanum, Jared L. Kneebone, Ellen Townley, Carolyn Bolton Moore, IMPAACT 2017 Team. Safety and pharmacokinetics of oral and long-acting injectable cabotegravir or long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study. Lancet HIV. 2024. 11: e211-e221. PMID: 38538160Year
2024
Journal
Lancet HIV
Study
IMPAACT 2017
Cognitive Behavioral Therapy Factors Related to Outcomes in Depression Among Youth with HIV
Citation
Betsy D. Kennard, Larry K. Brown, Kristin Baltrusaitis, Miriam Chernoff, Graham J. Emslie, Jessica Jones, Sarah Buisson, Jaime Deville, Megan Wilkins, Amber Bunch, Chivon McMullen Jackson, Christy Beneri, David E. Shapiro, IMPAACT 2002 Team. Cognitive Behavioral Therapy Factors Related to Outcomes in Depression Among Youth with HIV. Cognitive Therapy and Research. 2024. 48: 781-790. PMID: 39664885Year
2024
Journal
Cognitive Therapy and Research
Study
IMPAACT 2002